Translational activation by the noncoding RNA DsrA involves alternative RNase III processing in the rpoS 5'-leader

The intricate regulation of the Escherichia coli rpoS gene, which encodes the stationary phase sigma-factor sigmaS, includes translational activation by the noncoding RNA DsrA. We observed that the stability of rpoS mRNA, and concomitantly the concentration of sigmaS, were significantly higher in an RNase III-deficient mutant. As no decay intermediates corresponding to the in vitro mapped RNase III cleavage site in the rpoS leader could be detected in vivo, the initial RNase III cleavage appears to be decisive for the observed rapid inactivation of rpoS mRNA. In contrast, we show that base-pairing of DsrA with the rpoS leader creates an alternative RNase III cleavage site within the rpoS/DsrA duplex. This study provides new insights into regulation by small regulatory RNAs in that the molecular function of DsrA not only facilitates ribosome loading on rpoS mRNA, but additionally involves an alternative processing of the target.     

The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters

Recent studies have boosted our understanding of long noncoding RNAs (lncRNAs) in numerous biological processes, but few have examined their roles in somatic cell reprogramming. Through expression profiling and functional screening, we have identified that the large intergenic noncoding RNA p21 (lincRNA-p21) impairs reprogramming. Notably, lincRNA-p21 is induced by p53 but does not promote apoptosis or cell senescence in reprogramming. Instead, lincRNA-p21 associates with the H3K9 methyltransferase SETDB1 and the maintenance DNA methyltransferase DNMT1, which is facilitated by the RNA-binding protein HNRNPK. Consequently, lincRNA-p21 prevents reprogramming by sustaining H3K9me3 and/or CpG methylation at pluripotency gene promoters. Our results provide insight into the role of lncRNAs in reprogramming and establish a novel link between p53 and heterochromatin regulation.     

胰腺相关microRNAs研究进展

miRNAs是一类长约21-25nt的内源性的小非编码RNA(small noncoding RNA),它在基因的转录后调控中发挥着重要的作用。miRNAs可以通过与靶基因的mRNA的3'端UTR区完全或部分互补,进而降解该目的mRNA或阻止其翻译成相关蛋白,下调靶基因表达,以此参与个体发育、细胞分化、细胞增殖以及疾病发生过程中的基因表达调控。本文简要介绍miRNAs在胰腺发育、β细胞功能以及胰腺相关疾病中的研究进展。     

miRNAs的表达调控机制

microRNAs(miRNAs)是一类在转录后基因调控中发挥功能的非编码小RNAs,在发育、生长和分化等过程中发挥重要作用.至今已经在动物、植物和微生物等不同生物体中鉴定出来数千种miRNAs. miRNAs可以通过降解mRNA或抑制蛋白翻译的方式调节特异基因表达.生物体内约30%的基因都受miRNAs的调节.miRNAs的表达与功能受到转录因子、表观遗传学、多核苷酸多态性及其RNA编辑等多种因素的调节.此外,特异miRNA基因敲除的成功为研究miRNAs功能提供了有力的实验模型.     

长链非编码RNA顺式调节作用机制的研究进展

长链非编码RNA (long non-coding RNA, lncRNA)种类众多,生物学功能复杂,与不同的分子相互作用,实现其特有的基因调控功能。可参与细胞核染色质结构的调控、m RNA的转录及转录后的加工运输、蛋白质的翻译等过程。此外,lncRNAs在邻近基因或靶基因的顺式调节机制中也发挥了重要作用,本综述主要对近年来lncRNAs通过顺式调节作用影响基因表达的机制进行综述。     

循环长链非编码RNA作为生物标志物在肿瘤分子诊断中的应用

长链非编码RNA(Long noncoding RNA,lncRNA)被发现广泛参与基因表达、表观遗传调控和X染色体失活等重要生命过程,还与肿瘤发生和发展密切相关。lncRNA可能以微泡、外泌体或蛋白质复合物形式进入人体循环系统中,形成循环lncRNA稳定而广泛存在于血液、尿液等体液中。文中简要回顾了近来关于循环lncRNA的来源,以及作为生物标志物的检测方法,着重总结分析了循环lncRNA作为潜在肿瘤生物标志物在肺癌、乳腺癌、胃癌、肝癌、结直肠癌和前列腺癌等常见恶性肿瘤中的早期诊断价值。与传统生物标志物相比,循环lncRNA具有作为新型生物标志物的独特优势和临床应用价值。     

长链非编码RNA的免疫调节机制研究进展

真核生物的基因表达受多个层面调控,包括染色体水平、DNA水平、转录水平和转录后水平的调控等.长链非编码RNA(lnc RNA)是一类转录本超过200 nt的非编码RNA,其对基因表达的调控涉及上述各个层面,如组蛋白修饰、DNA甲基化的调控、转录的促进和抑制、m RNA的剪辑及对转录因子的调控等.其作用方式复杂多样,可与DNA、mRNA和蛋白质等相互作用而发挥调节作用.LncRNA保守性较差,但其表达却有较高的细胞、组织和分化阶段特异性.免疫系统的发育和分化受到精密的调控,且具有较高的阶段性和特异性.因此研究lnc RNA的功能及作用机制,免疫系统是较好的选择,这能促进我们对免疫调控的理解,为免疫性疾病的治疗提供新的思路和方法.本文主要介绍lnc RNA的分类和lnc RNA作用的一般分子机制,及其对T细胞、B细胞、固有免疫细胞和炎症因子的分子调控机制及其进展.